|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Biomarkers Speeding Drug Discovery and Development | ||||||||||||||||
| October 09, 2002 | ||||||||||||||||
|
Strategic Research Institute, San Digo, CA 12/06/2002 Proteomics without Polyacrylamide: Qualitative and Quantitative Approaches to Proteomics via Mass Spectrometry Post-Translational Modifications as a source for cancer biomarkers Serum Profiling for Biomarkers using Multidimensional. Chromatography, SDS-PAGE, and MALDI-TOF-MS. Multiplex Biomarker Analysis for Physiological Profiling. Shotgun Proteomics: Basic Science to Biomarkers |
||||||||||||||||
| Organized by: | Steve Kuperberg | |||||||||||||||
| Invited Speakers: | Post-Translational Modifications as a Source for Cancer Biomarkers Samir Hanash, M.D., Ph.D., University of Michigan Applications of Biomarker Discovery in Drug Development Gregory M. Preston Ph.D., Clinical Biochemical Measurements Group Genomic and Proteomic Sciences, Discovery Pfizer |
|||||||||||||||
| Deadline for Abstracts: | 12/05/02 | |||||||||||||||
| Registration: | 888-666-8514 | |||||||||||||||
| E-mail: | skuperberg@srinstitute.com | |||||||||||||||
| Posted by: | Jennifer Law | |||||||||||||||
| Host: | 12.3.58.15 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||